AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.
Prif Awduron: | , , , , , , , , |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
Elsevier
2023-10-01
|
Cyfres: | IBRO Neuroscience Reports |
Mynediad Ar-lein: | http://www.sciencedirect.com/science/article/pii/S2667242123010126 |